Responses
Other responses
Jump to comment:
- Published on: 30 April 2019
- Published on: 30 April 2019About "terminally ill"
The article assumes that discerning a category of terminally ill persons will be done fairly readily, with some minor controversy that can be ignored. This is not the case. Most of us now will die after a long period of decline, from any of a long list of illnesses and conditions associated with aging. The mean length of self-care disability for persons who make it to 65 years old is about 2 years. We built the concept of a 6 month prognosis on the experience with certain highly fatal cancers, where the usual time from onset of a clearly fatal course to death was well under 6 months. This trajectory is not the experience of persons dying with various causes of frailty, as most of us will experience. We will know that our Parkinson's or Alzheimer's or frailty (or whatever) will worsen through to death, but the timing of the dying will depend mostly on rather random events - an infection, a fall, or some such event when we have so little resilience. Another way to look at it is to try to define the statistical meaning of a prognosis of less than 6 months. Is it 51% likely to die within 6 months, or 91%, or 99%? To many people, this sounds like a silly set of questions, but the difference in the population made "eligible" for PAD (or hospice) is more than 1000-fold at each of these thresholds. And the "error rate" at 1 or 2 years is very different for different illnesses. A person who has a 51% chance of dying within 6 months from a ne...
Show MoreConflict of Interest:
None declared.
Other content recommended for you
- Treatment-resistant depression and physician-assisted death
- Competence for physician-assisted death of patients with mental disorders: theoretical and practical considerations
- Physician-assisted death does not violate professional integrity
- Treatment-resistant major depressive disorder and assisted dying
- Value promotion as a goal of medicine
- Suicide by advance directive?
- When slippery slope arguments miss the mark: a lesson from one against physician-assisted death
- Efficacy of repetitive transcranial magnetic stimulation in treatment-resistant depression: the evidence thus far
- Safeguarding choice at the end of life
- Why extra caution is needed in the case of depressed patients